XML 157 R140.htm IDEA: XBRL DOCUMENT v3.22.4
Parent Company Only Condensed Financial Information - Condensed Parent Company Only Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 102,311 $ 112,974 $ 64,024
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Net accretion of securities (882) (992) (129)
Amortization of junior subordinated debentures 556 530 506
Amortization of subordinated notes issuance costs 843 1,224 182
Stock based compensation 21,176 20,315 4,618
Change in other assets (35,176) (8,684) 12,215
Net cash provided by (used in) operating activities 74,487 136,959 97,327
Cash flows from investing activities:      
Proceeds from maturities, calls, and pay downs of securities held to maturity 679 1,003 693
Net change in loans 581,599 153,946 (632,517)
Net cash provided by (used in) investing activities 672,382 77,656 (774,737)
Cash flows from financing activities:      
Issuance of preferred stock, net of issuance costs 0 0 42,364
Preferred dividends (3,206) (3,206) (1,701)
Purchase of treasury stock (76,714) (1,241) (35,772)
Stock option exercises (74)   (227)
Stock option exercises   577  
Proceeds from employee stock purchase plan common stock issuance 1,548 449 0
Net cash provided by (used in) financing activities (721,865) (145,830) 793,923
Net increase (decrease) in cash and cash equivalents 25,004 68,785 116,513
Cash and cash equivalents at end of period 408,182 383,178 314,393
Cash and cash equivalents at beginning of period 383,178 314,393 197,880
Parent Company      
Cash flows from operating activities:      
Net income 102,311 112,974 64,024
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity in undistributed subsidiary income 1,427 (121,892) (58,501)
Net accretion of securities (171) (87) (221)
Amortization of junior subordinated debentures 556 530 506
Amortization of subordinated notes issuance costs 843 1,224 182
Stock based compensation 686 420 315
Credit loss expense (benefit) 362 56 1,900
Change in other assets (4,089) 387 337
Change in accrued expenses and other liabilities 3,650 546 505
Net cash provided by (used in) operating activities 105,575 (5,842) 9,047
Cash flows from investing activities:      
Investment in subsidiaries 0 3,383 146
Proceeds from maturities, calls, and pay downs of securities held to maturity 679 1,003 693
Net change in loans 0 0 719
Net cash provided by (used in) investing activities 679 4,386 1,558
Cash flows from financing activities:      
Proceeds from issuance of subordinated notes, net 0 68,224 0
Repayment of subordinated notes 0 (50,000) 0
Issuance of preferred stock, net of issuance costs 0 0 42,364
Preferred dividends (3,206) (3,206) (1,701)
Purchase of treasury stock (76,714) (1,241) (35,772)
Stock option exercises (74)   (227)
Stock option exercises   577  
Proceeds from employee stock purchase plan common stock issuance 1,548 449 0
Net cash provided by (used in) financing activities (78,446) 14,803 4,664
Net increase (decrease) in cash and cash equivalents 27,808 13,347 15,269
Cash and cash equivalents at end of period 92,338 64,530 51,183
Cash and cash equivalents at beginning of period $ 64,530 $ 51,183 $ 35,914